In vivo experiments demonstrated that Deu @ Cal MNs effectively down-regulated the psoriasis-associated IL-23/IL-17 pathway and inhibited epidermal hyperplasia, realizing the synergistic effect of immunomodulation and anti-proliferation, which provided a new therapeutic strategy for the treatment of psoriasis. Here, IL17A is linked to psoriasis.